California Proposes COVID-19 Sick Leave

California Proposes COVID-19 Sick Leave

[ad_1] Thursday, February 3, 2022 In late January, California Governor Gavin Newsom announced that he and the legislature had reached an agreement on a framework to revive COVID-19 supplemental paid sick leave (SPSL), which expired in September 2021. However, there was no bill and only speculation on what coverage would look like. On February 2, 2022, Assembly Bill 84, […]

Continue Reading
A different COVID-19 vaccine debate: Do we need new ones?

A different COVID-19 vaccine debate: Do we need new ones?

[ad_1] COVID-19 vaccines are saving an untold number of lives, but they can’t stop the chaos when a hugely contagious new mutant bursts on the scene, leading people to wonder: Will we need boosters every few months? A new vaccine recipe? A new type of shot altogether? That’s far from settled, but with the shots […]

Continue Reading
“SAVE Act” to prohibit medical discrimination based on COVID-19 vaccination status

“SAVE Act” to prohibit medical discrimination based on COVID-19 vaccination status

[ad_1] Posted: Feb 3, 2022 / 09:05 AM EST / Updated: Feb 3, 2022 / 09:05 AM EST WASHINGTON, D.C. (WSPA) – Congressman Jeff Duncan issued the following statement on co-sponsoring the SAVE Act, which would prohibit discrimination based on COVID-19 vaccination status against individuals seeking to donate or receive an organ. “Many employees were […]

Continue Reading
Coronavirus tally: White House to offer 400 million N95 masks to Americans from national stockpile

Eli Lilly stock gains after earnings rise above expectations, as COVID-19 antibodies revenue top $1 billion

[ad_1] Shares of Eli Lilly & Co. LLY, +1.03% rose 0.4% in premarket trading Thursday, after the drug giant reported fourth-quarter profit and revenue that rose above expectations, as COVID-19 antibodies revenue topped $1 billion, which was well above forecasts. Net income fell to $1.73 billion, or $1.90 a share, from $2.12 billion, or $2.32 […]

Continue Reading
The latest on Hawaii's COVID-19 travel requirements

The latest on Hawaii’s COVID-19 travel requirements

[ad_1] Hawaii Gov. David Ige signed a new COVID-19 emergency proclamation last week, keeping COVID-19 restrictions in place. It also adds that cruise ship passengers must abide by Safe Travels Hawaii program requirements. “Just a few weeks ago, Hawaii saw record high COVID-19 cases in our communities,” Ige said in a news release. “While we […]

Continue Reading
The Colorado Sun

Colorado is planning a shift to an “endemic response” to COVID-19

[ad_1] As Colorado shifts toward an endemic response to COVID-19, the state health department is looking to the private sector for help in rethinking strategies to deal with the presence of the virus forever, and appears to be trying to shed its central role in limiting its spread in the process. The Colorado Department of […]

Continue Reading
Singapore approves Pfizer's oral COVID-19 medicine Paxlovid

Singapore approves Pfizer’s oral COVID-19 medicine Paxlovid

[ad_1] Paxlovid, a Pfizer’s coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS /File Photo SINGAPORE, Feb 3 (Reuters) – Singapore has approved Pfizer’s (PFE.N) oral COVID-19 medicine Paxlovid, its Health Sciences Authority (HSA) said on Thursday. Paxlovid is […]

Continue Reading
close-btn

Ohio reports more than 8,600 new COVID-19 cases

[ad_1] For southwest Ohio, there were 728 inpatients who were COVID-19 positive, or about 1 in 4 patients. This region includes Butler, Warren, Clinton Hamilton, Clermont, Brown and Adams counties. Compared to three weeks ago, the number of COVID-19 patients in southwest Ohio region hospitals has fallen 26%. Explore‘It doesn’t matter how healthy you are. […]

Continue Reading
Valneva says early studies show COVID-19 vaccine effective against Omicron

Valneva targets 2022 revenue boost on COVID-19 vaccine

[ad_1] The logo of French-Austrian biotech firm Valneva is seen outside their headquarters in Vienna, Austria, December 16, 2021. REUTERS/Lisi Niesner Register now for FREE unlimited access to Reuters.com Register Feb 3 (Reuters) – French vaccine developer Valneva (VLS.PA) expects its COVID-19 vaccine candidate to considerably boost its yearly sales in 2022, after they already […]

Continue Reading
Roche sees slower 2022 sales growth as COVID-19 test demand eases

Roche sees slower 2022 sales growth as COVID-19 test demand eases

[ad_1] A box of material for rapid COVID-19 antigenic tests made by Swiss drugmaker Roche is pictured at the University Hospital (CHUV) during the coronavirus disease (COVID-19) outbreak, in Lausanne, Switzerland, November 13, 2020. REUTERS/Denis Balibouse Register now for FREE unlimited access to Reuters.com Register Feb 3 (Reuters) – Swiss drugmaker Roche said sales growth […]

Continue Reading